Effect of a Sacral Lift on Femoral Vein Size and Exposure
Launched by ALLEGHENY SINGER RESEARCH INSTITUTE (ALSO KNOWN AS ALLEGHENY HEALTH NETWORK RESEARCH INSTITUTE) · Apr 1, 2025
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether using a sacral lift can help improve the size and visibility of the femoral vein, which is important for certain medical procedures in the emergency department. Specifically, the researchers want to find out if the sacral lift makes the vein larger and easier to see, especially when patients are lying in different positions. Participants will undergo ultrasound scans of their femoral vein while lying straight and in a frog-leg position, both with and without the sacral lift, to see if it really makes a difference.
To be eligible for this study, you must be an adult patient in the emergency department, aged between 18 and 85. However, if you have certain medical conditions, such as a history of deep vein thrombosis (DVT) or previous surgeries on your lower legs, you may not qualify. If you choose to participate, you can expect to have a simple ultrasound procedure to help the researchers gather the information they need. This study is not yet recruiting participants, but it aims to help improve medical practices in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult emergency department patients.
- Exclusion Criteria:
- • \<18 or \>85 years-old
- • Anyone with a history of: deep venous thrombosis (DVT), May-Thurner syndrome, lower extremity vein harvesting, arterial or venous surgery of the lower leg (e.g., peripheral arterial stent placement or sclerotherapy of lower extremity varicose veins), or peripheral vascular disease.
- • Anyone with a medical condition that could impact their physical ability to lay supine or abduct and externally rotate their hips safely (e.g., hip fracture).
- • Anyone whose femoral vessels cannot be clearly identified using a linear transducer
- • Anyone whose femoral vein is not compressible on the study ultrasound (indicating a DVT). If 100% of the femoral vein is already exposed from under the femoral artery with a straight leg (right or left), the patient will be excluded from the study.
- • Vulnerable populations such as pregnant women and those who cannot consent.
About Allegheny Singer Research Institute (Also Known As Allegheny Health Network Research Institute)
The Allegheny Singer Research Institute, part of the Allegheny Health Network, is a leading clinical research organization dedicated to advancing medical knowledge and improving patient care through innovative research initiatives. With a strong emphasis on collaboration and interdisciplinary approaches, the institute conducts a wide range of clinical trials across various therapeutic areas, focusing on translating scientific discoveries into effective treatments. Committed to the highest ethical standards and patient safety, the Allegheny Singer Research Institute aims to enhance healthcare outcomes while fostering a culture of excellence in research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Erie, Pennsylvania, United States
Patients applied
Trial Officials
Principal Investigator Dhimitri Nikolla, DO, MS, FACEP, FACOEP
Principal Investigator
Allegheny Health Network
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported